Headline News

 

Astellas to showcase late stage oncology portfolio at ASCO 2026 with long term follow up data

Posted on May 19, 2026

Sanofi’s efdoralprin alfa beats standard-of-care augmentation therapy in Phase 2 AATD study

Posted on May 19, 2026

BEQALZI wins US accelerated approval in relapsed/refractory mantle cell lymphoma

Posted on May 19, 2026

Regeneron’s Phase 3 fianlimab combination misses primary endpoint in first-line advanced melanoma

Posted on May 19, 2026

Astrazeneca’s IMFINZI cuts early recurrences in high-risk non-muscle-invasive bladder cancer

Posted on May 19, 2026

Astrazeneca’s ENHERTU secures two new US approvals in HER2-positive early breast cancer

Posted on May 19, 2026

BAXFENDY approved in the US as first-in-class aldosterone synthase inhibitor for hypertension

Posted on May 19, 2026

Roche signs definitive merger agreement to buy PathAI in bid to advance AI-powered diagnostics

Posted on May 11, 2026

Johnson & Johnson launches Generation Fine, a new movement encouraging patients to expect more from depression treatment and aim for remission

Posted on May 11, 2026

Thermo Fisher Scientific’s clinical research business named a leader among CROs in 2026 ISG Provider Lens report for use of AI in clinical trials

Posted on May 11, 2026

Lilly’s Omvoh is the first IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years

Posted on May 11, 2026

CNS drug delivery breakthroughs unlock significant biotech market opportunities

Posted on May 11, 2026

GSK partners with SBP Group to accelerate bepirovirsen launch across China

Posted on May 11, 2026

Avalo Therapeutics hits primary endpoint in Phase 2 hidradenitis suppurativa trial

Posted on May 11, 2026

Cytokinetics hits on both primary endpoints in pivotal non-obstructive HCM trial

Posted on May 11, 2026